rhodioloside has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gai, Y; Huang, J; Li, L; Luan, Y; Pan, J; Xiao, L; Xu, Z | 1 |
| Fu, C; Huang, Y; Liu, WQ; Liu, XZ; Lv, P; Meng, L; Wang, XB; Wang, XH; Wang, YF; Yang, Q; Zhao, LP; Zheng, DY; Zuo, ZF | 1 |
2 other study(ies) available for rhodioloside and Brain Disorders
| Article | Year |
|---|---|
Salidroside attenuates lipopolysaccharide-induced neuroinflammation and cognitive impairment in septic encephalopathy mice.
Topics: Animals; Anti-Inflammatory Agents; Brain Diseases; Cognitive Dysfunction; Cytokines; Lipopolysaccharides; Mice; Neuroinflammatory Diseases; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Sirtuin 1 | 2023 |
Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain Diseases; Caspase 3; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoglycemia; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2023 |